Metraipolis › archive › dc_09090073741d

Exploring murE protein inhibitors of Tropheryma whipplei through pharmacoinformatic approaches incorporating solubility-enhancing formulation insights — Europe PMC PMID:40894227

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40894227
DOI
10.3389/fphar.2025.1630038
License (as archived)
solo-consultazione
Archived
2026-11-10T15:53:42.087Z
SHA-256 of the archived text
859275ecad2a10107a0f431b2534377f2eec45a6261f6b2fc01464fcc1f0bc04
Stable URL of this page
https://metraipolis.com/documento/dc_09090073741d

How to cite

Exploring murE protein inhibitors of Tropheryma whipplei through pharmacoinformatic approaches incorporating solubility-enhancing formulation insights — Europe PMC PMID:40894227 — Europe PMC (en), https://europepmc.org/article/MED/40894227 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_09090073741d (Metraipolis archive dc_09090073741d, sha256 859275ecad2a10107a0f431b2534377f2eec45a6261f6b2fc01464fcc1f0bc04)
BibTeX
@misc{dc09090073741d,
  title = {Exploring murE protein inhibitors of Tropheryma whipplei through pharmacoinformatic approaches incorporating solubility-enhancing formulation insights — Europe PMC PMID:40894227},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40894227},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_09090073741d; sha256 859275ecad2a10107a0f431b2534377f2eec45a6261f6b2fc01464fcc1f0bc04},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40894227. Agents can read the archived copy with the MCP tool read_document.